Effects of Kojic Acid-mediated Sonodynamic Therapy as a Matrix Metalloprotease-9 Inhibitor against Oral Squamous Cell Carcinoma: A Bioinformatics Screening and in vitro Analysis
CONCLUSIONS: Overall, Kojic acid-mediated SDT as an MMP-9 inhibitor can be a promising adjuvant treatment for OSCC. The study highlights the potential of in silico approaches to evaluate therapeutic methods for cancer treatment.PMID:38073102 | DOI:10.2174/0115701638266082231124055825
Source: Current Drug Discovery Technologies - Category: Drugs & Pharmacology Authors: Maryam Pourhajibagher Mojgan Alaeddini Shahroo Etemad-Moghadam Steven Parker Abbas Bahador Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Genetics | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology | Ultrasound